Emcure Pharmaceuticals Profit & Loss Annual

BSE: 544210 | NSE: EMCURE | ISIN: INE168P01015 | Sector: -
1,277.75 +21.55 (1.72%)Updated : 10 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 6,821.655,750.875,070.564,769.93
Other Net 67.26-21.27-14.68-15.92
Diluted Weighted Average Shares 18.7018.9118.9118.91
Depreciation/ Amortization 384.13312.41260.12244.86
Operating Income 1,074.35907.39915.251,085.46
Net Income 681.33498.18532.02662.20
Income Availableto Com Excl Extra Ord 681.33498.18532.02662.20
Other Operating Expenses Total 1,834.25919.76829.78785.84
Net Income Before Taxes 971.35727.23747.21972.55
Minority Interest -26.14-29.39-29.83-40.36
Net Income After Taxes 707.47527.58561.85702.56
Income Availableto Com Incl Extra Ord 681.33498.18532.02662.20
Costof Revenue Total 3,146.602,595.462,369.112,330.43
Gross Profit 4,749.394,062.793,616.703,524.95
Interest Inc( Exp) Net- Non- Op Total -170.26-166.08-153.03-96.58
Unusual Expense( Income) 10.389.936.15-
Diluted Net Income 681.33498.18532.02662.20
DPS- Common Stock Primary Issue 3.00---
Provisionfor Income Taxes 263.88199.65185.37269.99
period Type ----
Net Income Before Extra Items 681.33498.18532.02662.20
Total Revenue 7,896.006,658.255,985.815,855.39
period Length 12.0012.0012.0012.00
Revenue 7,896.006,658.255,985.815,855.39
Selling/ General/ Admin Expenses Total 1,446.291,913.311,605.411,408.80
Diluted Normalized EPS 36.8326.4528.3935.03
Diluted EPS Excluding Extra Ord Items 36.4326.3528.1335.02
Gain( Loss)on Saleof Assets -7.19-0.33-0.41
*All figures in crores except per share values
Recommended For You
Trending Stocks
12,666.00+197.40(1.58%)
853.95+13.15(1.56%)
161.05+2.05(1.29%)
1,975.00-43.00 (-2.13%)
1,612.95-20.95 (-1.28%)